Gladstone in the News
The Gladstone Institutes is gratified to receive media attention from around the globe. Check out the highlights of recent press coverage of Gladstone scientists and research. For other news, please be sure to follow us on Facebook and Twitter.
A team of scientists at the Gladstone Institutes has identified a new way to make latent HIV reveal itself, which could help overcome one of the biggest obstacles to finding a cure for HIV infection. They discovered that increasing the random activity, or noise, associated with HIV gene expression - without increasing the average level of gene expression - can reactivate latent HIV. Their findings were published in the journal Science.
For decades, most researchers ignored the leading genetic risk factor for Alzheimer's disease. That is set to change, thanks in large part to pioneers at Gladstone.
Three scientists, including Gladstone's Melanie Ott, MD, PhD, have been chosen to receive the 2014 Avant-Garde Award for HIV/AIDS Research from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health. The three scientists will each receive $500,000 per year for five years to support their research.
A potent source of genetic variation in cognitive ability has just been discovered by Gladstone's Lennart Mucke, MD, and UCSF's Dena Dubal, MD, PhD.
A gene variant that scientists already knew to be associated with longer life also seems to make people smarter, and may help offset the effects of normal cognitive decline in old age, according to a team of researchers from the Gladstone Institutes and UCSF.
A hormone associated with longevity also appears to make people's brains work better. The finding in Cell Reports could someday lead to drugs that improve memory and learning, say researchers at the Gladstone Institutes and UCSF.
Gladstone Investigator Yadong Huang, MD, PhD, sheds light on why women are more likely to develop Alzheimer's than men—which, suggests Huang, may make some future treatments more effective for one gender than the other.
Gladstone's Sheng Ding, PhD, the William K. Bowes, Jr. Distinguished Investigator, uses a revolutionary chemical reprogramming technique to turn skin cells into functional pancreas, liver, and heart cells.
Cardiovascular medicine at Stanford University and the Gladstone Institutes looks to stem cells for answers.
Gladstone Director of Virology and Immunology, Warner C. Greene, MD, PhD, weighs in on Gilead's efforts to develop a functional cure for HIV.